DalsnaFinance › IPOs › Artiva Biotherapeutics › IPO
Artiva Biotherapeutics, Inc. completed its initial public offering on NASDAQ on July 19, 2024, pricing at $12.00 a share.
| Ticker | ARTV |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | July 19, 2024 |
| Offering price | $12.00 |
| Shares offered | 13,920,000 |
| Total raised | $167M |
Artiva Biotherapeutics, Inc. sold 13,920,000 shares at $12.00 each on NASDAQ. Multiplied out, that is $167 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $167 million total recorded for the deal.
Artiva Biotherapeutics, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Artiva Biotherapeutics, Inc.. This page is general information, not investment advice.